Published in West J Med on March 01, 1981
Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev (1970) 4.48
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86
Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A (1979) 3.48
Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med (1978) 3.42
Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation (1974) 3.33
Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med (1979) 3.29
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation (1976) 2.87
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Hyperlipidemia and atherosclerosis. Science (1976) 2.55
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
RELEASE OF A PLATELET-AGGREGATING SUBSTANCE (ADENOSINE DIPHOSPHATE) FROM RABBIT BLOOD PLATELETS INDUCED BY SALINE "EXTRACT" OF TENDONS. Thromb Diath Haemorrh (1963) 2.32
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet (1974) 2.29
Platelet and fibrinogen consumption in man. N Engl J Med (1972) 2.20
Interrelations of platelet aggregation and secretion. J Clin Invest (1977) 1.93
Thromboatherosclerosis in normolipemic rabbits. A result of continued endothelial damage. Lab Invest (1973) 1.87
Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest (1977) 1.84
Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation (1977) 1.83
Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest (1974) 1.76
Regulation of blood platelet function by cyclic nucleotides. Adv Cyclic Nucleotide Res (1978) 1.65
The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest (1977) 1.58
Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet (1978) 1.53
Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol (1974) 1.51
Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest (1980) 1.42
Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood (1979) 1.33
Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest (1967) 1.33
Platelet interaction with polymerizing fibrin. J Clin Invest (1972) 1.31
Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion. Circulation (1978) 1.27
Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins. Am J Physiol (1977) 1.25
Intravascular platelet aggregation in the heart induced by norepinephrine. Microscopic studies. Circulation (1972) 1.23
On the formation and effects of thromboxane A2 in human platelets. Acta Physiol Scand (1976) 1.22
Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol (1978) 1.22
Indium-111-labeled autologous platelets for location of vascular thrombi in humans. J Nucl Med (1978) 1.21
The tissue factor pathway of blood coagulation. Prog Hemost Thromb (1972) 1.19
Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance. Am Heart J (1978) 1.18
Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta (1978) 1.14
Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. Atherosclerosis (1974) 1.13
Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol (1976) 1.13
Platelet function studies in coronary artery disease. Circulation (1973) 1.12
Platelet studies in patients with coronary artery disease and in their relatives. Br Heart J (1972) 1.12
Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol. Circulation (1978) 1.08
Vitamin E. An inhibitor of the platelet release reaction. J Clin Invest (1976) 0.98
A radioimmunoassay for platelet factor 4. Thromb Res (1976) 0.95
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest (1979) 0.94
Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Lab Invest (1977) 0.94
Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med (1975) 0.94
Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antinflammatory drugs. Thromb Res (1978) 0.90
Endothelium 1977: a review. Adv Exp Med Biol (1978) 0.90
Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol (1977) 0.87
Platelet function in hyperbetalipoproteinemia. Thromb Haemost (1978) 0.85
Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction. Circulation (1980) 0.84
Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation. Am J Cardiol (1972) 0.84
The influence of antiplatelet drugs on platelet survival after aortic damage or implantation of a dacron arterial prothesis. Thromb Res (1979) 0.83
Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation. Thromb Res (1979) 0.82
The action of halofenate on platelet shape change and prostaglandin synthesis. J Lab Clin Med (1978) 0.80
Phospholipase A2 and platelet aggregation. Adv Prostaglandin Thromboxane Res (1978) 0.80
Plasma concentrations of platelet-specific proteins correlated with platelet survival. Blood (1980) 0.79
Platelet survival in patients previously resuscitated from out-of-hospital ventricular fibrillation. J Lab Clin Med (1979) 0.77
Platelet-suppressant therapy in patients with coronary artery disease. JAMA (1978) 0.77
Clinical and pathological aspects of arterial thrombosis and thromboembolism. Adv Exp Med Biol (1978) 0.77
Myocardial lesions in sudden, unexpected coronary death. Am Heart J (1975) 0.76
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Thrombogenesis in sickle cell disease. J Lab Clin Med (2001) 2.75
The bleeding time as a screening test for evaluation of platelet function. N Engl J Med (1972) 2.73
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50
Bleeding complications associated with cardiopulmonary bypass. Blood (1990) 2.43
Platelet and fibrinogen consumption in man. N Engl J Med (1972) 2.20
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Ferrokinetics in man. Medicine (Baltimore) (1970) 2.08
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med (1970) 1.99
Thrombokinetics in man. J Clin Invest (1969) 1.99
Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest (1984) 1.94
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
Effective and efficient platelet transfusion strategies that maintain hemostatic protection. Transfusion (1998) 1.86
Exaggerated platelet reactivity in major depression. Am J Psychiatry (1996) 1.72
Neutrophil kinetics in man. J Clin Invest (1976) 1.72
Experimental acute thrombotic stroke in baboons. Stroke (1987) 1.64
Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res (1980) 1.63
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation (1990) 1.52
Interpretation of electrocochleography in Menière's disease and normal subjects. Ann Otol Rhinol Laryngol (1992) 1.48
Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation (1991) 1.47
Kinetics of thrombopoiesis. J Clin Invest (1968) 1.43
Activated neutrophils disrupt endothelial monolayer integrity by an oxygen radical-independent mechanism. Lab Invest (1985) 1.40
Circulatory Support 1988. Bleeding and anticoagulation. Ann Thorac Surg (1989) 1.38
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci U S A (1988) 1.34
Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke (1988) 1.34
Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood (1982) 1.32
Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol (1976) 1.32
Mechanisms of thrombocytopenia in varicella. Am J Hematol (1979) 1.30
Magakaryocyte quantitation. J Clin Invest (1968) 1.29
Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res (1983) 1.24
Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function. Ann Surg (1977) 1.24
Characteristics of murine megakaryocytic colonies in vitro. Blood (1979) 1.22
Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res (1983) 1.22
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thromb Diath Haemorrh (1974) 1.22
Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest (1984) 1.21
Interactions of vascular wall cells with collagen gels. Lab Invest (1982) 1.20
Preparation of cryoprecipitated factor VIII concentrates. Transfusion (1977) 1.19
Studies of human plate alpha-granule release in vivo. Blood (1981) 1.19
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest (1993) 1.17
Facial paralysis in the newborn. Otolaryngol Head Neck Surg (1982) 1.17
Central venous stenosis in the hemodialysis patient: incidence and efficacy of endovascular treatment. Cardiovasc Surg (1997) 1.16
Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. J Lab Clin Med (1989) 1.14
Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol (1976) 1.13
Evaluation of storage iron by chelates. Am J Med (1968) 1.13
Flow cytometric analysis of normal human megakaryocytes. Blood (1988) 1.10
Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumours. Br J Haematol (1982) 1.10
Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood (1989) 1.08
Thrombolytic therapy in stroke: possibilities and hazards. Stroke (1986) 1.08
Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol (1984) 1.07
Neutrophil kinetics in the dog. J Clin Invest (1975) 1.07
Left ventricular thrombi: in vivo detection by indium-111 platelet imaging and two dimensional echocardiography. Am J Cardiol (1981) 1.06
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res (1997) 1.06
Hemostasis in malignancy. Ann N Y Acad Sci (1974) 1.05
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med (1982) 1.05
Bleeding after cardiopulmonary bypass. N Engl J Med (1986) 1.04
Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest (1988) 1.03
Human endothelial cell migration: stimulation by a released platelet factor. Lab Invest (1978) 1.01
In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombosis. J Lab Clin Med (1980) 1.00
Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost (2001) 1.00
Lithium enhancement of megakaryocytopoiesis in culture: mediation via accessory marrow cells. Blood (1983) 1.00
Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis (1985) 0.99
Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol (1970) 0.98
Mechanism of action of dipyridamole. Thromb Res Suppl (1983) 0.97
The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. Stroke (1986) 0.97
The prevalence of migraine in Menière's disease. Laryngoscope (1992) 0.96
Purification of human megakaryocytes by fluorescence-activated cell sorting. Blood (1987) 0.96
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood (1998) 0.96
Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest (1998) 0.96
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest (1985) 0.95
Physiology of the nose. Otolaryngol Clin North Am (1973) 0.95
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest (1979) 0.94
The role of endothelial cell injury and platelet response in atherogenesis. Thromb Haemost (1978) 0.94
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol (1987) 0.94
Marrow erythroid and neutrophil cellularity in the dog. J Clin Invest (1975) 0.93
Megakaryocytopoiesis in the mouse: response to varying platelet demand. J Cell Physiol (1981) 0.92
Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials. Ann Intern Med (1989) 0.91
The relation of platelet density to platelet age: survival of low- and high-density 111indium-labeled platelets in baboons. Blood (1986) 0.90
Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. J Biol Chem (1990) 0.90
Kinetics of the formed elements of human blood. Blood (1977) 0.90
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). N Engl J Med (1975) 0.90
Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood (1991) 0.90
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J (1986) 0.90
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation (1996) 0.90
The kinetics of platelet production and destruction in man. Clin Haematol (1977) 0.89
The endothelium and thrombosis. Annu Rev Med (1980) 0.89
On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. Prostaglandins (1984) 0.89
Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ Res (1992) 0.89
Section preparation of human marrow for light microscopy. J Clin Pathol (1976) 0.89
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. Circulation (1986) 0.88
Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb (1992) 0.88
Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. Blood (1981) 0.88
Binding and release of factor VIII/von Willebrand's factor by human endothelial cells. Br J Haematol (1980) 0.87
Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol (1977) 0.87
Prophylactic balloon angioplasty fails to prolong the patency of expanded polytetrafluoroethylene arteriovenous grafts: results of a prospective randomized study. J Vasc Surg (1997) 0.87
Disorders of platelet function: mechanisms, diagnosis and management. West J Med (1981) 0.87
Middle cranial fossa acoustic neuroma excision: results and complications. Ann Otol Rhinol Laryngol (1986) 0.87